Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma.
Hedvat CV, Hegde A, Chaganti RS, Chen B, Qin J, Filippa DA, Nimer SD, Teruya-Feldstein J
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of IHC staining of TMA versus whole section slides to evaluate protein expression in lymphoma specimens. In addition, ISH and IHC methods were compared for the detection of EBV. 2-3 cores for each specimen were on the TMA. When discrepancies were noted between two cores on the same TMA, the authors report the higher value.
Summary of Findings
Between 21 and 55 TMA and whole section slides were examined by IHC for each antibody. In almost all cases, CD30, cyclin-D1, CD5, CD3, and CD20 IHC staining results were the same on TMA and whole section slides. CD10 staining also showed 95% agreement between slide types. However, Bcl-2, CD23, and CD43 IHC staining results had lower concordance rates and agreement (K=0.66, 88% agreement; K=0.53, 86% agreement; and K=0.77, 88% agreement, respectively) between TMA and whole section slides. False negatives obtained by staining TMA sections accounted for 70% of the discrepant results. When the presence of EBV was detected by IHC staining for LMP1 and by ISH using probes for EBER-1 and EBER-2, similar results were obtained by ISH and IHC for 26 of 27 specimens. The discrepant case was EBV+ by IHC and EBV- by ISH.
Biospecimens
TissueLymph NodeTissueSpleenTissueTonsilTissueThymus GlandPreservation Types
FormalinOther PreservativeDiagnoses
NormalNeoplasticLymphomaPlatforms
ProteinImmunohistochemistryProteinTissue microarrayRNAIn situ hybridizationPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Biospecimen location Lymph nodeSpleenThymusTonsilBiospecimen Aliquots and Components Type of slide Tissue microarrayWhole sectionBiospecimen Preservation Type of fixation/preservation B-3 fixativeFormalin (buffered)In situ hybridization Specific Targeted nucleic acid EBER-1EBER-2In situ hybridization Specific Technology platform ImmunohistochemistryImmunohistochemistry Specific Targeted peptide/protein Bcl-2CD10CD20CD23CD3CD30CD43CD5Cyclin D1LMP1